194 related articles for article (PubMed ID: 19156348)
1. Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study.
Pouwels S; van Staa TP; Egberts AC; Leufkens HG; Cooper C; de Vries F
Osteoporos Int; 2009 Sep; 20(9):1499-506. PubMed ID: 19156348
[TBL] [Abstract][Full Text] [Related]
2. The risk of bone fracture after long-term risperidone exposure is not increased compared to other atypical antipsychotics: A retrospective cohort study.
Shen SP; Liu Y; Qiu H; Tsai KY; Wu HC; Liang WM; Shu M; Chou FH
PLoS One; 2019; 14(9):e0221948. PubMed ID: 31487309
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study.
Arbouw ME; Movig KL; van Staa TP; Egberts AC; Souverein PC; de Vries F
Osteoporos Int; 2011 Jul; 22(7):2197-204. PubMed ID: 20967420
[TBL] [Abstract][Full Text] [Related]
4. Conventional or atypical antipsychotics and the risk of femur fracture among elderly patients: results of a case-control study.
Liperoti R; Onder G; Lapane KL; Mor V; Friedman JH; Bernabei R; Gambassi G
J Clin Psychiatry; 2007 Jun; 68(6):929-34. PubMed ID: 17592919
[TBL] [Abstract][Full Text] [Related]
5. Use of anti-depressants and the risk of fracture of the hip or femur.
van den Brand MW; Pouwels S; Samson MM; van Staa TP; Thio B; Cooper C; Leufkens HG; Egberts AC; Verhaar HJ; de Vries F
Osteoporos Int; 2009 Oct; 20(10):1705-13. PubMed ID: 19238308
[TBL] [Abstract][Full Text] [Related]
6. Risk of hip/femur fractures in patients using antipsychotics.
Hugenholtz GW; Heerdink ER; van Staa TP; Nolen WA; Egberts AC
Bone; 2005 Dec; 37(6):864-70. PubMed ID: 16111927
[TBL] [Abstract][Full Text] [Related]
7. Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study.
Pouwels S; Lalmohamed A; Souverein P; Cooper C; Veldt BJ; Leufkens HG; de Boer A; van Staa T; de Vries F
Osteoporos Int; 2011 Mar; 22(3):903-10. PubMed ID: 20585937
[TBL] [Abstract][Full Text] [Related]
8. Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis.
Lee SH; Hsu WT; Lai CC; Esmaily-Fard A; Tsai YW; Chiu CC; Wang J; Chang SS; Lee CC
Osteoporos Int; 2017 Apr; 28(4):1167-1178. PubMed ID: 28083669
[TBL] [Abstract][Full Text] [Related]
9. Exposure to risperidone versus other antipsychotics and risk of osteoporosis-related fractures: a population-based study.
Clapham E; Bodén R; Reutfors J; Svensson T; Ramcharran D; Qiu H; Kieler H; Bahmanyar S
Acta Psychiatr Scand; 2020 Jan; 141(1):74-83. PubMed ID: 31545521
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic treatment and the risk of hip fracture in subjects with schizophrenia: a 10-year population-based case-control study.
Wu CS; Chang CM; Tsai YT; Huang YW; Tsai HJ
J Clin Psychiatry; 2015 Sep; 76(9):1216-23. PubMed ID: 26115407
[TBL] [Abstract][Full Text] [Related]
11. Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study.
de Vries F; Pouwels S; Lammers JW; Leufkens HG; Bracke M; Cooper C; van Staa TP
J Intern Med; 2007 Feb; 261(2):170-7. PubMed ID: 17241182
[TBL] [Abstract][Full Text] [Related]
12. Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: a systematic review.
Pratt N; Roughead EE; Salter A; Ryan P
BMC Med Res Methodol; 2012 Jun; 12():72. PubMed ID: 22682666
[TBL] [Abstract][Full Text] [Related]
13. Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands.
de Vries F; Souverein PC; Cooper C; Leufkens HG; van Staa TP
Calcif Tissue Int; 2007 Feb; 80(2):69-75. PubMed ID: 17308987
[TBL] [Abstract][Full Text] [Related]
14. Use of beta-2 agonists and risk of hip/femur fracture: a population-based case-control study.
de Vries F; Pouwels S; Bracke M; Leufkens HG; Cooper C; Lammers JW; van Staa TP
Pharmacoepidemiol Drug Saf; 2007 Jun; 16(6):612-9. PubMed ID: 16998945
[TBL] [Abstract][Full Text] [Related]
15. Psychotropic-related hip fractures: meta-analysis of first-generation and second-generation antidepressant and antipsychotic drugs.
Oderda LH; Young JR; Asche CV; Pepper GA
Ann Pharmacother; 2012; 46(7-8):917-28. PubMed ID: 22811347
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic Drugs and Hip Fracture: Associations Before and After the Initiation of Treatment.
Brännström J; Lövheim H; Gustafson Y; Nordström P
J Am Med Dir Assoc; 2020 Nov; 21(11):1636-1642.e6. PubMed ID: 32768373
[TBL] [Abstract][Full Text] [Related]
17. Use of alpha-blockers and the risk of hip/femur fractures.
Souverein PC; Van Staa TP; Egberts AC; De la Rosette JJ; Cooper C; Leufkens HG
J Intern Med; 2003 Dec; 254(6):548-54. PubMed ID: 14641795
[TBL] [Abstract][Full Text] [Related]
18. Risk of hospitalization for hip fracture and pneumonia associated with antipsychotic prescribing in the elderly: a self-controlled case-series analysis in an Australian health care claims database.
Pratt N; Roughead EE; Ramsay E; Salter A; Ryan P
Drug Saf; 2011 Jul; 34(7):567-75. PubMed ID: 21663332
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic Use and the Risk of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease.
Koponen M; Taipale H; Lavikainen P; Tanskanen A; Tiihonen J; Tolppanen AM; Ahonen R; Hartikainen S
J Clin Psychiatry; 2017 Mar; 78(3):e257-e263. PubMed ID: 28146612
[TBL] [Abstract][Full Text] [Related]
20. Schizophrenia, antipsychotics and risk of hip fracture: a population-based analysis.
Sørensen HJ; Jensen SO; Nielsen J
Eur Neuropsychopharmacol; 2013 Aug; 23(8):872-8. PubMed ID: 23642346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
